PATIENTS WITH COVID-19 are more likely to develop psychiatric disorders. And, having a psychiatric disorder can increase the risk of getting Covid-19.
One in five Covid-survivors received a diagnosis of anxiety, depression, or insomnia within three months of testing positive for SARS-CoV-2. People with a pre-existing psychiatric diagnosis were 65 per cent more likely to be diagnosed with Covid-19 than those without. The findings were published in The Lancet Psychiatry.
The WHO is not recommending the use of the antiviral drug remdesivir for patients with Covid-19 because the drug has not shown any effective impact on survival, the need for ventilation or time to clinical improvement. The WHO guideline on drugs for Covid-19 was published in The BMJ.
According to a study published in Science Advances the best way to limit transmission (apart from wearing a mask) while travelling in a taxi or other ride-sharing modes of commute is to keep all four windows down and have the passenger sit in the back on the opposite side from the driver.
An Archives of Disease in Childhood study suggests that healthier blood vessels and a stronger immune system are likely the factors that protect children from severe Covid-19.
THE FIRST BLOOD test that can help diagnose Alzheimer’s disease goes on sale in the US, even though it has not received approval from the US Food and Drug Administration.
Developed by C2N Diagnostics, the PrecivityAD™ test measures the concentrations of two types of amyloid particles as well as the presence of apolipoprotein E isoforms in the blood. The results are then combined with other data such as a person’s age to determine their risk of having amyloid buildup in the brain, which is a hallmark of Alzheimer’s disease.
The blood test report includes a score that shows a low, intermediate or high probability of having amyloid plaques in the brain.
The blood test is intended only for people 60 or older suffering from thinking and memory problems.
According to the company, in a study of 686 patients, aged 60 and older, with cognitive impairment or dementia, the blood test correctly identified brain amyloid plaque buildup in 86 per cent of the patients when the results were compared with PET scans.
The best method to diagnose Alzheimer’s is a PET scan which can be very costly. The blood test is cheap and non-invasive and can be easily accessible.
MEAL TIMINGS MATTER
ACCORDING TO A STUDY presented at the American Heart Association's Scientific Sessions conference, inconsistent meal times can negatively impact your cardiovascular health.
Greater meal time inconsistency is associated with higher body mass index, waist circumference, blood pressure and fasting glucose.
The findings were based on a study of 116 women aged 20 to 64. The women recorded their meal timings and diet for a week using an electronic food diary.
The researchers looked at day-to-day changes in eating timing, duration of the eating period, evening eating and differences in eating patterns on weekdays versus weekends.
Each one hour increase in the difference between first meal time on weekdays compared to weekends was associated with higher body mass index, diastolic blood pressure and systolic blood pressure.
Each one hour increase in the difference between weekdays vs weekend nightly fasting duration was associated with higher body mass index, fasting glucose and systolic blood pressure. Greater inconsistency in nighttime eating was associated with higher waist circumference.
WORLD'S NO 1 KILLER
CARDIOVASCULAR DISEASES, especially ischaemic heart disease and stroke, are the leading cause of death worldwide, accounting for one-third of all deaths globally in 2019, according to review published in the Journal of the American College of Cardiology.
The review was based on data from The Global Burden of Diseases, Injuries, and Risk Factors Study 2019, which examined all “available population-level data sources on incidence, prevalence, case fatality, mortality and health risks to estimate measures of population health for 204 countries and territories”.
Cardiovascular disease cases nearly doubled from 271 million in 1990 to 523 million in 2019. The number of cardiovascular disease deaths also steadily increased from 12.1 million in 1990 to 18.6 million in 2019.
Most of the cardiovascular disease deaths were from ischaemic heart disease and stroke.
In 2019, 9.6 million men and 8.9 million women died from cardiovascular diseases. More than 6 million of these deaths occurred in people between the ages of 30 and 70.
The number of years lived with heart disease-related disability doubled to 34.4 million in 2019 from 17.7 million in 1990.
NOT FIT FOR CHILDREN
GIVING CHILDREN ANTIBIOTICS before age two can increase their risk of several chronic conditions, including asthma, hay fever, food allergies, eczema, celiac disease, obesity and attention deficit hyperactivity disorder.
For the study published in the journal Mayo Clinic Proceedings, the researchers followed 14,572 children born between 2003 and 2011, for nearly eight years.
Among them, 70 per cent were given at least one antibiotic prescription during their first two years, with most receiving multiple antibiotics.
The association varied with the gender, and number, type and timing of antibiotic exposure. The risk was greatest when babies were exposed to antibiotics within the first six months. The risk increased when kids were exposed to several courses of antibiotics.
The risk also differed with different antibiotics. Use of cephalosporins was associated with the highest risk for multiple health conditions.
Girls exposed to antibiotics were more susceptible to eczema and celiac disease, while boys were more susceptible to obesity.
Early exposure to antibiotics could alter the baby’s microbiome during critical developmental periods which can have long-term health consequences.
DID YOU KNOW?
Regular participation in organised sports could help reduce behavioural problems in young boys with development delays.
The Journal of Pediatrics
WHILE ALCOHOL CONSUMPTION can be harmful throughout a person’s life, Australian and British researchers have identified three life stages when the brain is most susceptible to the damaging effects of alcohol.
The negative effects of alcohol are most prominent during gestation (from conception to birth), later adolescence (15-19 years), and older adulthood (over 65 years)—three periods when the brain is going through dynamic changes.
Heavy alcohol use during pregnancy can cause foetal alcohol spectrum disorder, which can lead to reductions in brain volume and cognitive impairment. Even low or moderate alcohol consumption is associated with poorer psychological and behavioral outcomes in offspring.
Binge-drinking in adolescence is associated with reduced brain volume, poorer white matter development (critical for efficient brain functioning), and a range of cognitive functioning issues.
In older people, alcohol use is one of the strongest modifiable risk factors for all types of dementia, especially early onset, compared with other known risk factors such as high blood pressure and smoking.
Even moderate drinking can lead to significant brain shrinkage in midlife. The study was published in The BMJ.
DID YOU KNOW?
Eating tree nuts, such as almonds, hazelnuts and walnuts, daily can improve sperm quality.
THE END OF INSULIN SHOTS?
A GROUNDBREAKING procedure could help people with type 2 diabetes stop insulin therapy.
Researchers from the Netherlands used the minimally-invasive procedure—Duodenal Mucosal Resurfacing—which rejuvenates the lining of the duodenum, in combination with daily doses of a class of diabetes medication called glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and lifestyle counselling.
During DMR, an endoscope is used to resurface, or ablate, the lining of the duodenum, the first part of the small intestine that is connected to the stomach.
The preliminary study included 16 patients who underwent DMR. The participants had type 2 diabetes for an average of 11 years and had been on insulin for about three years.
Six months after the procedure, 75 per cent of the patients no longer needed insulin. At 12 months, their average A1C levels (average blood glucose levels over three months) fell to 6.7.
The average body mass index of patients who responded to the treatment fell from 29.8 to 25.5 after 12 months. The percentage of fat in their liver also dropped from 8.1 per cent to 4.6 per cent at six months.
Patients who still needed insulin after the procedure were able to reduce their insulin dose by more than half—from 35 units per day at the start of the study to 17 units per day at 12 months.
DID YOU KNOW?
Long-term androgen deprivation therapy was associated with an almost four-fold increased risk of cardiovascular mortality and reduced cardiorespiratory fitness in prostate cancer patients with high risk of cardiovascular disease.
DELAYED FERTILITY AFTER STOPPING CONTRACEPTION
HOW LONG WILL it take for fertility to return after women stop using contraceptives?
To find out, researchers examined data from 17,954 Danish and American women. The women provided information about their contraceptive history, as well as personal, medical, and lifestyle information, at the start of the study and then answered follow-up questionnaires every two months for up to 12 months or until they became pregnant.
The most commonly used method of contraception was oral contraceptives, followed by barrier methods and natural methods. About 13 per cent of the women used long-acting reversible contraceptive methods, such as IUDs and injectable contraceptives.
Almost 56 per cent of women conceived within six menstrual cycles of stopping contraceptives, and 77 per cent within twelve cycles. Return to fertility varied depending on the contraceptive method used. Women who used injectable contraceptives had the longest delay in return of normal fertility (five to eight cycles), followed by users of patch contraceptives (four cycles), users of oral contraceptives and vaginal rings (three cycles), and users of hormonal and copper intrauterine devices and implant contraceptives (two cycles).
The study was published in The BMJ.
CONTRIBUTOR: SHYLA JOVITHA ABRAHAM